INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
7.93
+0.66 (9.08%)
Jun 4, 2025, 1:55 PM - Market open

INmune Bio Market Cap

INmune Bio has a market cap or net worth of $184.06 million as of June 4, 2025. Its market cap has decreased by -16.70% in one year.

Market Cap
184.06M
Enterprise Value
154.62M
1-Year Change
-16.70%
Ranking
Category
Stock Price
$7.93

Market Cap Chart

Since February 4, 2019, INmune Bio's market cap has increased from $77.82M to $184.06M, an increase of 136.50%. That is a compound annual growth rate of 14.56%.

History

DateMarket Cap% Change
Jun 3, 2025168.74M62.96%
Dec 31, 2024103.55M-48.97%
Dec 29, 2023202.92M78.35%
Dec 30, 2022113.78M-37.49%
Dec 31, 2021182.00M-21.41%
Dec 31, 2020231.57M270.69%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 662.23B
Johnson & Johnson 373.45B
AbbVie 328.75B
Novo Nordisk 305.07B
UnitedHealth Group 273.87B
Abbott Laboratories 232.41B
AstraZeneca 224.00B
Novartis AG 223.92B
Market Cap Rankings